作者: Ki-Woon Kang , Jaemin Shim , Jinhee Ahn , Dae In Lee , Jun Kim
DOI: 10.3904/KJM.2018.93.2.140
关键词: Review article 、 Heart disease 、 Internal medicine 、 Atrial fibrillation 、 Cardiology 、 Clinical trial 、 Combination therapy 、 Sinus rhythm 、 Pharmacotherapy 、 Catheter ablation 、 Medicine
摘要: Rhythm control therapy is the main strategy for restoring and maintaining sinus rhythm in patients with non-valvular atrial fibrillation (NVAF). Sinus better restored maintained antiarrhythmic drugs than placebo treatment. In addition, catheter ablation or combination more effective treating NVAF. However, most clinical trials to date, has resulted neutral outcomes compared rate therapy. The decision undergo should be based on age, (AF)-related symptoms, type of AF, structural heart disease, underlying comorbidities. For now, indicated improve symptoms NVAF who have refractory after adequate Korean Heart Society organized AF Management Guideline Committee analyzed all available data, including South This review article provides general principles detailed methodology NVAF. (Korean J Med 2018;93:140-152)